By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Horizon Pharma plc 

Connaught House, 1st Floor
1 Burlington Road
Dublin 4      Ireland
Phone: +353-1-72-2100 Fax:


SEARCH JOBS








Company News
Depomed (DEPO)'s Board Of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal From Horizon Pharma (HZNP) 7/30/2015 12:58:30 PM
Horizon Pharma (HZNP) Announces Collaboration With Fox Chase Cancer Center To Study ACTIMMUNE (Interferon Gamma-1b) In Combination With PD-1/PD-L1 Inhibitors In Various Forms Of Cancer 7/27/2015 11:35:20 AM
Depomed (DEPO) Confirms Receipt Of Purported Revised, Highly Conditional, Unsolicited Proposal From Horizon Pharma (HZNP) 7/21/2015 2:14:15 PM
Horizon Pharma (HZNP) Increases Offer For Depomed (DEPO) To $33.00 Per Share 7/21/2015 9:17:52 AM
Depomed (DEPO) Gets Sweetened $33 Per Share Offer From Horizon Pharma (HZNP) 7/21/2015 6:27:52 AM
Horizon Pharma (HZNP) Responds To Depomed (DEPO)'s Adoption Of A Poison Pill 7/15/2015 12:09:05 PM
Horizon Pharma (HZNP) Names Tina E. Ventura Vice President, Investor Relations 7/9/2015 10:49:34 AM
Horizon Pharma (HZNP) Goes Hostile With $3 Billion Bid for Depomed (DEPO) 7/7/2015 6:13:40 AM
Horizon Pharma (HZNP) Files Patent Infringement Lawsuits Against Five Companies For Filing Abbreviated New Drug Applications For PENNSAID(R) (Diclofenac Sodium Topical Solution) 2% 7/6/2015 11:02:18 AM
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID(R) (Diclofenac Sodium Topical Solution) 2% 7/2/2015 10:33:34 AM
12345678910...
//-->